-14-1791962797.jpeg)
CUPERTINO, California - October 14, 2026 - CARPL.ai, the world’s largest radiology AI marketplace and enterprise imaging AI platform, today announced a strategic partnership with Cortechs.ai, a global leader in AI-powered neuroimaging solutions. Through this collaboration, Cortechs.ai’s suite of advanced AI imaging solutions will be available through the CARPL.ai platform, expanding global access to quantitative neuroimaging tools that support more precise diagnoses, streamlined workflows, and improved patient care.
The partnership will make Cortechs.ai’s industry-leading solutions, including NeuroQuant®, NeuroQuant® MS, NeuroQuant® Brain Tumor, NeuroQuant® CT, NeuroQuant® PET, NeuroQuant® Lesion Surveillance, and OnQ™ Prostate, more easily accessible to healthcare organizations through CARPL.ai’s unified AI ecosystem. By integrating these applications into existing clinical workflows, radiologists and clinicians can seamlessly leverage advanced quantitative imaging insights without disrupting day-to-day operations.
“We are excited to partner with CARPL.ai to broaden access to our AI-powered imaging solutions worldwide,” said Jared Dixon, Executive VP of Sales for Cortechs.ai. “CARPL.ai’s extensive marketplace and enterprise imaging platform align perfectly with our mission to bring clinically impactful, quantitative imaging tools to providers in a seamless and scalable way. Together, we’re helping healthcare organizations accelerate AI adoption while enhancing diagnostic confidence and workflow efficiency.”
CARPL.ai’s platform enables healthcare institutions to discover, explore, validate, and deploy imaging AI applications across their enterprise through a single integration point. The collaboration with Cortechs.ai further strengthens CARPL.ai’s growing ecosystem of clinically validated AI applications designed to support radiologists and healthcare systems globally.
“Cortechs.ai brings a proven suite of imaging AI solutions that help quantify brain structures, track neurological and neurodegenerative conditions, support lesion surveillance, assist in brain tumor assessment, and aid prostate cancer imaging. At CARPL.ai, our focus is on helping healthcare organizations evaluate, deploy, and scale clinically meaningful AI within real world radiology workflows. This partnership brings Cortechs.ai’s quantitative imaging capabilities into CARPL’s enterprise AI ecosystem, helping radiologists and clinicians gain more objective insights, improve diagnostic confidence, and deliver better patient care.” Dhruv Sahai, COO, CARPL.ai
The partnership underscores both companies’ commitment to advancing the adoption of AI in radiology and delivering scalable solutions that integrate seamlessly into enterprise imaging environments.
For more information, visit www.cortechs.ai and www.carpl.ai.
About Cortechs.ai
Cortechs.ai is a leader in AI applications in radiology. Cortechs.ai uses cutting-edge technologies in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, healthier lives. The company develops and markets breakthrough medical device software that quantifies and tracks neurodegenerative diseases and assists in the detection of clinically significant cancer. Cortechs.ai’s industry-leading brain imaging software provides radiologists, neurologists, oncologists, and clinical researchers worldwide with a convenient and cost-effective way to quantify brain structures for assessing Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, and other brain abnormalities. The company’s numerous FDA-cleared products provide quantitative insights to help physicians with the diagnosis and follow-up of neurodegenerative and traumatic brain conditions, as well as prostate cancer. Please visit www.cortechs.ai for further information and follow us on Twitter, LinkedIn, and Facebook.
About CARPL.ai
CARPL.ai is an end-to-end enterprise imaging AI platform, and the world’s largest radiology AI marketplace offering 300+ applications from 100+ AI Partners. With regulatory clearances across multiple regions including the FDA, CE, ANVISA, TGA, HSA, and Health Canada, CARPL.ai enables radiologists and researchers to easily access, assess, and integrate radiology AI applications into their clinical practice. CARPL.ai provides a single user interface, a single data channel, and a single procurement channel for the testing, deployment, and monitoring of AI applications in clinical radiology workflows. The CARPL.ai platform is used by four out of the world’s top five radiology groups, and integrates with leading PACS systems, including Philips, AGFA HealthCare, DeepHealth, Intelerad, RamSoft, and Paxera Health, ensuring seamless interoperability across imaging environments. Learn more at www.carpl.ai.
